Atakan Sokak No:22/6 Mecidiyeköy Şişli/İstanbul
Gynecology Obstetrics and Reproductive Medicine (GORM) publishes a wide range of peer-reviewed papers in the field of obstetrics (maternal-fetal neonatal medicine), gynecology, gynecologic oncology, urogynecology & reproductive medicine and edited by an international interdisciplinary team of authorities in this field since 1994. GORM is is supported by “Maternal-Fetal Medicine and Perinatology Society of Turkey” and "The SouthEast European Society of Perinatal Medicine" and "Turkish Neonatal Society".
The journal’s foremost aim is to present a platform for scientists and academicians in SouthEast Europe and all over the world to cooperate and debate for progressing on controversial issues and in different areas of obstetrics and gynecology.
GORM publishes original, peer-reviewed experimental and clinical studies, case reports, and reviews in all fields related to obstetrics (maternal-fetal neonatal medicine), gynecology, gynecologic oncology, urogynecology & reproductive medicine. All of the originality, priority, scientificity, and actuality criteria must be met by the papers accepted to be published. All the papers adding new information to the current field and have a chance to make it interesting for the readers will be accepted for review.
The editors will hand back the manuscript to the author without review if they think that the paper is not suitable for publication.
GORM publishes three issues per year in April, August, and December.
GORM publishes manuscripts only in English. The manuscripts presented to GORM should be clear and succinct in terms of language. Furthermore, its language should observe the rules of grammar, and scientific literature and manuscripts must have a plain and clear language quality. The journal does not have any translation services for this purpose, but the manuscripts of the author(s) without a good English proficiency are recommended to be edited by a professional translator or native English speaker, or some accredited companies before submission. The author is responsible for the adjustment of suggestions made by section editors or reviewers.
In cases where manuscripts by authors whose native language is not English are accepted for publication, the manuscripts should be submitted to the editorial board after their translation and editing are done by professional people or companies. When the author(s) are to have their manuscript edited, they may do so by referring to one of the companies below and present a related document to the editorial board afterward.
American Journal Experts (AJE), https://www.aje.com/en
Boston BioEdit, http://www.bostonbioedit.com
Elsevier Language Services, http://webshop.elsevier.com/languageservices/
Editorial Rx, http://www.editorialrx.com
SPI Publisher Services, http://www.prof-editing.com
Wiley Editing Services, http://wileyeditingservices.com/en/
Take into consideration that the publisher or journal does not ratify the vendors in the list. We promote authors to search for each service and additional vendors providing similar services by themselves.
Gynecology, Obstetrics & Reproductive Medicine (GORM) publishes experimental and clinical articles, case reports, and reviews. Subgroups are as follows;
We have moved to the new website in 2016 with open-access features, but we have also published the retrospective available archive as open access.
GORM adopts the policy of open access and every open-access article will be at once and always free for everyone to read and download. If the author and the citation to the source are given the credit, articles can be utilized constructively by everyone. There is no need to get permission from the authors or publishers. The articles of this journal can be accessed through search engines, websites, blogs, and other digital platforms.
GORM provides scientists, scholars, academicians, researchers, and students with Open Access platform in which they can publish their work to support them. Open access to information enhances the information’s global value and so it is beneficial for humanity. The Budapest Open Access Initiative was signed on September 12, 2012, and GORM also supports it. Thus, the list of open access policies that the editorial board of GORM adopted can be seen at http://budapestopenaccessinitiative.org.
GORM publishes all articles under a Creative Commons Attribution 4.0 License (CC BY 4.0). This license entitles all parties to copy, share and redistribute all the articles, data sets, figures, and supplementary files published in this journal in data mining, search engines, websites, blogs, and other digital platforms under the condition of providing references. Open access is an approach that eases the interdisciplinary communication and encourages cooperation among different disciplines. GORM, therefore, contributes to its own field by providing more access to its articles and a more transparent review process. GORM recommends that libraries include the article contents into library catalog records.
Since GORM claims no fees for article processing and no subscription fees for access to articles, the only source of income is advertisement and hard copy sales.
The authors consent to give all the personal information to the system by submitting the information asked by GORM. GORM is determined to provide you with confidence and trust in terms of the privacy of personally identifiable information. You may get periodic e-mails or notices about the journal and upcoming events after you provide your e-postal address to GORM.
Any personal information will be used exclusively for this journal and scientific aims. Such information will not be used for other purposes and will not be shared with third parties. The only exclusion is in terms of legal situations such as court orders, rights to defend against claims, prevention from illegal activities, etc.
Gynecology, Obstetrics, and Reproductive Medicine s an open-access journal that aims to create a transparent publishing policy. We think that sharing datasets is a crucial step for creating transparency. Shared datasets would contribute to the literature even more and sharing data is a great way for validation of the published studies. Furthermore, data sharing would enable other authors to contribute to the current study. Creating easily accessible datasets may also lead to opportunities for further studies.
The following text summarizes the data privacy policies of Gynecology, Obstetrics, and Medicine.
We fully encourage our authors to deposit and share their relevant data except in cases with ethical issues regarding human rights or data privacy. There are several ways of data deposit and share. Gynecology, Obstetrics, and Reproductive Medicine fully support all of the described modules which may be found online. We fully support the usage of relevant and well-known data repository sites. There are many well-known data repository sites and each one would be used for these purposes.
Authors are also questioned about the data available regarding their study. The terms should also clarify when the dataset is available and who can reach these datasets. Additionally, one of the following options should be selected and noted by the authors;
a. Data are available in an open Access public repository.
b. Data are available upon request.
c. Data are not publicly available but may be obtained from a third party.
d. There are no specific data regarding this study.
e. All of the data are included in the manuscript and uploaded as supplementary material.
f. Data is unavailable.
Manuscripts with a readily available dataset will add a data availability statement including the URL for reaching the repository storing the data. Authors with a preloaded dataset and a DOI number are asked to include the DOI number in their data availability statement.
Authors or readers demanding a dataset that is available upon request may contact the corresponding author. In case of no return, the authors or readers demanding the dataset may contact the editorial board.
All the authors are encouraged to share their datasets and may contact the editorial board for further questions.
All the issues published in GORM will be listed on our website in XML and pdf formats with open access to attain them. Also, you can reach the stored papers in pdf format on ULAKBİM servers via TÜBİTAK ULAKBİM National Databases. GORM has a data depositing function installed via PKP Preservation Network (PKP PN) that digitally preserves the Journals regulating under Open Journal System (OJS).
GORM does not offer a sponsorship to protect the journal’s integrity. On the other hand, please contact to our editorial team for information on advertising or to request a media pack.
GORM accepts advertising for products and services that are of interest to users professionally. The sources of income of GORM include institutional support (Maternal-Fetal Medicine and Perinatology Society of Turkey, Turkish Neonatal Society and South East European Society of Perinatal Medicine), display advertising for pharmaceutical and non-pharmaceutical products and subscription fee for printed material.
Institutions wishing to place an advertisement in the printed version of the journal or on the web page should contact Medical Network Publishing.
Medical Network Publishing
Phone: +90 212 230 27 68
Email: [email protected]
GORM does not claim for any charges during the publishing stages (article submission, review, processing, and publication) and no subscription fees are required for accessing the published articles. There is no fee for the authors unless they want printed copies.
Manuscripts to be presented must be arranged according to the Article Template below.
Page Format: 22 x 28 cm (8 ½ x 11 inch) Portrait. All manuscripts should be handed in the format of Microsoft Word (.doc or .docx). Times New Roman with a font size of 12 must be used. Use double-space in each manuscript page (including references, tables, and figure legends). Leave 1-inch (2.5 cm) margins at top, bottom, and sides of the manuscripts. Give consecutive numbers to the pages on the upper right corner in the following order: title page, abstract, and body of text, acknowledgments, references, figure legends, and tables.
The manuscript must be presented with a cover letter and the title page including the details of authors. Ethics committee certificate must be submitted as a separate file. Due to the regulations of TR DIZIN the studies without ethical committee approval cannot be evaluated in the review process. Blinded manuscript with no author details must be submitted as the 4th separate file.
The title should be prepared separately from the manuscript. It should be clear and comprehensive. Abbreviations or commercial names and conclusive or question posing statements should not be used in the title. The title of the manuscript is not allowed to be longer than 100 characters. The title page should contain respectively the title, author line with first name, middle initial (or first initial and middle name if the the middle name is the real name in that country) and last name of all authors (in English characters) and each author’s ORCID numbers and highest academic degree (honors degrees are not but both MD and PhD are accepted); city (ies), where the study was carried out; divisional, or departmental, and institutional affiliations when the study was conducted; and where they practice (with the university name if present).
Name, address, business and home telephone numbers, and fax number of author to whom requests for reprints should be addressed (if reprints will not be available, it should be so stated); and name, address, business and home telephone numbers, and fax number of author responsible for correspondence concerning the manuscript if different from author to whom reprint requests are addressed.
Title page must also include acknowledgment, availability of data/materials, author contribution, and conflict of interest statements.
All source(s) of financial support: presented line, if applicable; disclaimers, if any support should be acknowledged in the title page.
The following must be included in the manuscript:
Abstracts must be on the first page of the manuscript. The goal of the study, method, results & original value should be included briefly and clearly in the abstract. All points in the abstract should be in accordance with the information given in the tables, text, or figures. Commercial names should not be used in the abstract.
You must type the abstract with double space and also the required margins and there should be the title of the article and name(s) of author(s) on the top. 3 to 5 key words or short phrases should be listed below the abstract for indexing purposes.
Original research articles, case reports, and short communication articles should have a structured abstract; therefore the author(s) should present the manuscript with an abstract selected and prepared appropriately. This applies to society manuscripts, as well as the ones submitted independently.
There can be 250 words maximum in a structured abstract. The following main headings must be included in the structured abstract; Objective(s); Study Design; Results; and Conclusion(s). The aim of the study which is the hypothesis being tested is reflected in the Objective(s). The setting of the study, the subjects (number and type), the treatment or intervention, and the type of statistical analysis must be mentioned in the Study Design. If appropriate, the result of the study and statistical significance are included in the Results include and the significance of the results are stated in the Conclusion(s).
The layout of a standard abstract is required for invited Topic, Treatment/Review, New Trends, and short communication articles. The standard abstracts must be 50 to 250 words.
When more appropriate to the information you wish to convey, you should not hesitate using the first person and active voice when writing your manuscript. As the passive voice highlights the “action,”, not the person performing the action, it is usually more effective to define techniques or observations.
Abbreviations other than the standard are not allowed. They are to be limited to a practical minimum use in the text. As long as it is not a standard unit of measurement, the full term represented by the abbreviation must be placed before using it in the text for the first time. Generic, chemical or proprietary names of drugs may be used. In cases in which the generic or chemical name is utilized, authors may, if they wish, put the proprietary name between brackets after mentioned in the text for the first time, with the name of the manufacturer and city and country.
Experimental and Clinical Articles
Standard articles are traditionally arranged with the following sections: An “Introduction” and titles that identify “Material and Methods”, “Results” and “Discussion”. In the Discussion section, a short summary of the findings may be written. The manuscript should not be informative about the identity of the authors.
The purpose and rationale for the study must be stated concisely in the introduction and only the most relevant references should be cited as background. The basis of the research topic, the importance of the subject in the literature, the importance of the study, research problem and aims should be explained in the introduction.
Material and Methods
The type, limitations and approval of ethical committee, experimental animals and other species, validity and reliability, data analysis, the plan, material, data collection techniques, and controls, the methods and procedures utilized, the patients and the statistical method(s) employed should be shortly identified in the Material and Methods section.
The findings must be given in the Results section in detail. Each table and/or figure should be mentioned. Figures and tables should supplement, not duplicate, the text; it will be enough to present the data in either one or the other. Only your important observations must be highlighted; your observations should not be compared with those of others. Only the Discussion section must include such comparisons and comments.
You should include the importance and significance of your findings in the Discussion section but do not repeat the same details stated in the Results section. Your opinions must be restricted to those strictly indicate by the facts in your report. Your findings must be compared with those of others. In this section, do not present any new data. Strengths and weaknesses of the study, unexplained questions and recommendations for future research should be marked. References should be chosen from the most recent publications.
All persons who have contributed to the work but not sufficiently to be authors should be acknowledged. Authors should mark if the manuscript had been presented at a meeting as an/a oral/poster presentation (congress/symposium name, dates and location of the meeting).
If the manuscript is the result of the MD thesis of the author this should be stated.
Author Contributions Statement
In the Author contributions section, a short statement detailing the contributions of each author should be included. Types of contributions can be given as; conception and design, data collection and analysis, experiments, writing the first draft, and supervision, etc. Approval of the final version by all authors should be stated. Submissions will not be accepted which do not include "Author Contributions Statements" after 2021.
A case report shortly describes an unusual condition or authentic diagnostic or treatment approach. The report must have a clear purpose and message. The abstract of case reports must limited to 125 words. There are three parts in case report articles:
Introduction: Should explain the importance of the case.
Case(s): Describes the case(s) and the essential findings.
Discussion: Should give a short review of the literature but and touch mainly upon the clinical implications.
All case report submissions should be appropriate for the recommendations of International Committee of Medical Journal Editors’ (ICMJE). It is advised to report with the guidance of CARE Checklist (2013) (http://www.care-statement.org) is recommended.
Written informed consent must be acquired for the patients with identifiable information mentioned in submission. Consents must be acquired from patients. Consents may be required from relatives or parents in the case of unable or deceased patients.
The submissions without consents will only be considered in the existence of sufficient anonymous presentation of case according to ICMJE guidelines.
Acquired informed consents must be mentioned in the manuscript. GORM has right to request copies of original consent at any time. For all submissions, Editor will make the final decision for the existence of personally identifiable information.
A review article is a complete review of publications concerning a specific clinical subject and proposing essential conclusions.
These invited articles provide concise reviews on a topic in which the author has expertise. The manuscript should be comprehensive and balanced, but not exhaustive. Expert Reviews must be on the basis of evidence but they may contain some expert opinion and recommendations. The goal is to provide a concise update on the state of the art and guidelines for clinical care. Expert Reviews can be 5000 words of main text maximum. Key words or short phrases as needed for indexing must be provided.
This category’s all articles present an inclusive and rather detailed systematic review of the literature concerning the topic, collating all relevant evidence meeting pre-specified eligibility criteria. Other manuscript types may not be integrated with systematic reviews.
Systematic reviews must include a clearly stated set of objectives with reproducible methodology, a systematic search, eligibility criteria for selecting studies, assessment of study quality (risk of bias), an assessment of the validity of the findings and systematic synthesis of these findings. Meta-analysis, the use of statistical techniques to combine and summarize results across studies, may or may not be contained within a systematic review.
Authors must adhere to the PRISMA and MOOSE guidelines (http://www.equator-network.org) and (https://www.equator-network.org).
Systematic Reviews can be 5000 words of main text maximum (not including legends, figures, references, condensation, acknowledgements, the title page, tables and abstract). Include a structured abstract containing 350 words at most and as many alphabetized key words or short phrases as needed for indexing.
Title: The title must identify the report as systematic review or metaanalysis
Abstract: Include a structured summary according to PRISMA guidelines with the following headings:
Headings and subheadings in the main text should include the following; note that subheadings may be modified to best represent the specific report.
The term figure includes all types of illustrations such as graphs, diagrams, photographs, flow charts, and line drawings. A reasonable number of figures (<5) will be reproduced without charge, but special arrangements must be made with the Editors for color figures at an additional charge to the author. The quoted charge is per page of color, and as many as eight color figures can be included on one page if the color balance is appropriate. Figures must be cited consecutively in the text in Arabic numerals. Consistency in size within the article is strongly preferred. Any special instructions regarding sizing should be clearly noted.
Legends for all figures must be typed together in numeric order double-spaced on the final page of the manuscript. Original magnifications should be provided, if a figure has been taken from copyrighted material, the legend must give full credit to the original source.
Tables should be submitted on separate pages and included at the end of the reference list and before the figure legends. Maximum number of tables to be allowed is 5. They should be numbered in Roman numerals. Each table must be cited in sequence at an appropriate point in the text. Titles should be brief yet indicate clearly the purpose or content of each table, and each column should be precisely defined by headings. Abbreviations and special designations should be explained in a footnote to the table. If a table or any part thereof has been taken from copy-righted material, a footnote to the table must give full credit to the original source. Arrangements must be made with the Editors for elaborate tables because of space limitations.
Bibliography is prepared according to the format of the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (“NLM” style, ICMJE sample references). To cite a source using the National Library of Medicine (NLM) style, insert a number into your text in round brackets.
A reasonable number (40) is allowed, except in case reports and brief communications (limited to 15) and in manuscripts for the invited topic, treatment/review and new trends sections (for which there is no limit). References must be double-spaced and numbered consecutively as they are cited. References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned. Authors are responsible for the accuracy of all references. Use the format of the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” National Library of Medicine (NLM) style (list the first 6 authors followed by 'et al.' if there are more than 6 authors. Year; volume(issue): page(s). DOI - if available. PMID and PMCID- if available and use official abbreviations for titles of journals (if available). As an option, if a journal carries continuous pagination throughout a volume (as many medical journals do) the month and issue number may be omitted. Journal titles should conform to abbreviations used in Cumulated Index Medicus.
Endnote style is available at https://endnote.com/style_download/national-library-of-medicine-nlm/
Examples (list the first six authors followed by et al.):
Standard journal article:
Unal C, Tanacan A, Fadiloglu E, Portakal O, Beksac MS. Effect of anti-epileptic drugs on first trimester screening test results. Taiwan J Obstet Gynecol. 2020 Nov;59(6):835-837. doi: 10.1016/j.tjog.2020.09.009. PMID: 33218397.
More than six authors:
Beksac MS, Fadiloglu E, Cakar AN, Gurbuz RH, Atilla P, Onbasilar I et al. Fetal Cell Microchimerism; Normal and Immunocompromised Gestations in Mice. Fetal Pediatr Pathol. 2020 Aug;39(4):277-287. doi: 10.1080/15513815.2019.1651803. Epub 2019 Aug 22. PMID: 31436120.
Chapter in a book
Moore TR, Hauguel-de Mouzon S, Catalano P. Diabetes in Pregnancy. In: R Resnik, CJ Lockwood, TR Moore, MF Greene, JA Copel and RM Silver, editors. Creasy & Resnik’s Maternal-Fetal Medicine. 8 th ed. Philadelphia: Elsevier; 2019. p. 1067-1097.
Personal communications and unpublished data, if essential, may be used but not as numbered references. If they are used, they are to be referred to, within parentheses, at the appropriate location in the text. If used, the author(s) must obtain written and signed permission for their use from the individual being quoted. This signed permission must accompany the manuscript when it is submitted to the Editor. Published abstracts can be used as numbered references; however, reference to the complete published article is preferred.
Gynecology Obstetrics and Reproductive Medicine (GORM) advises authors to adhere to the reporting guidelines available for many different study designs when drafting their study. These contain a checklist of minimum points that the authors should cover in their manuscript. A list full of all of the reporting guidelines endorsed by the EQUATOR Network can be found here.
Reporting guidelines for main study types are:
CONSORT (for reporting randomized controlled trials): Please submit a copy of the CONSORT checklist, available at http://www.equator-network.org/reporting-guidelines/consort/
STROBE (for reporting observational studies): Please submit a copy of the STROBE Checklist, available at http://www.equator-network.org/reporting-guidelines/strobe/
PRISMA (for reporting meta-analyses and systematic reviews of randomized controlled trials): Please submit a copy of the PRISMA Checklist, available at http://www.equator-network.org/reporting-guidelines/prisma/
MOOSE (for reporting meta-analyses and systematic reviews of observational studies): In your cover letter, please describe how you followed the MOOSE guidelines, available at http://dx.doi.org/10.1001/jama.283.15.2008.
STARD (for reporting studies of diagnostic accuracy): Please submit a copy of the STARD Checklist, available at http://www.equator-network.org/reporting-guidelines/stard/
CARE (for reporting case reports): Please submit a copy of the CARE Checklist, available at http://www.equator-network.org/reporting-guidelines/care/
SQUIRE 2.0 (for reporting on quality improvement in health care): Please submit a copy of the SQUIRE 2.0 checklist, available at http://www.equator-network.org/reporting-guidelines/squire
ARRIVE (for reporting animal pre-clinical studies): Please submit a copy of the ARRIVE checklist, available at http://www.equator-network.org/reporting-guidelines/arrive
Gynecology Obstetrics and Reproductive Medicine (GORM) also strongly encourages authors to use industry-recognized reporting guidelines such as SRQR, SPIRIT, AGREE and others when appropriate, to clarify that minimum reporting requirements have been met. Click here for links to the reporting guidelines, and for further information, visit www.equator-network.org
As noted above, we ask authors to address all items recommended by the guidelines (as a minimum); where this is not possible please provide an explanation in the text to give a transparent account of your study. If there are items on the checklist that you cannot attest to, please itemize these in your cover letter with an explanation. For manuscripts that require reporting guidelines, a checklist or explanation in the cover letter must accompany the submission. The manuscript will be returned to the author if this information is not included in the initial submission. Adherence to recommended reporting guidelines will facilitate review of your manuscript, increase the probability of its successful publication, and improve the usability of research findings from your study in further research and clinical practice.
All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.
All authors retain the copyright of their papers without restrictions. Authors only grant the publisher non-exclusive publishing rights (the right of first publishing) to publish the articles.
All submitted articles are subject to initial appraisal by Editor-in-Chief or one of the Editors/Section Editors before peer review. We reject a number of articles without external peer review with the aim of giving authors rapid decisions (usually within 10 days). We aim to reach a first decision on all manuscripts within six weeks of submission. Rejection is often much quicker than this. We aim to do this quickly so that we do not waste authors' time, allowing them to get on and submit the work elsewhere without unnecessary delay.
All research articles, and most other article types, published in GORM undergo thorough peer review. GORM operates an open peer review system. Also this journal uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. To facilitate this, authors need to ensure that their manuscripts are prepared in a way that does not give away their identity. To help with this preparation please ensure the following when submitting to GORM. Submit the Title Page containing the Authors details and Blinded Manuscript with no author details as 2 separate files.
If a submission is assigned to a Scientific Editor to process, he/she usually obtains reviews from at least two external referees to ensure the scientific quality and importance of the research. Editors will make a decision based on the reviewers’ reports and authors are sent these reports along with the editorial decision on their manuscript. Authors should note that even in light of one positive report, concerns raised by another reviewer might fundamentally undermine the study and result in the manuscript being rejected.
Authors must submit all elements of their manuscripts online at https://gorm.com.tr. Hard-copy submissions and submissions sent by e-mail will not be considered. All correspondence, including notification of the Editor's decision and requests for revision takes place via email.
All policies of the GORM, including those related to Conflicts of Interest, Inappropriate Acts, and ethics committee approval; apply to all submitted articles, including those whose results were presented at professional society meetings.
The purpose of an appeal is for the Editor-in-Chief or the Editors to examine the editorial process. If it is found not to have been in line with our policies, solving action will be taken to restore correct procedure.
The opinions/decisions given by the referees or editors are not reconsidered during an appeal. Overturning the majority view of referees and consulted editors just because of a single person (i.e. the Editor-in-Chief or a Deputy Editor-in-Chief) would not be appropriate. In general, two referees and three editors express an opinion and 3 votes, also the Editor-in-Chief’s approval should be supporting the publication so that a paper can be accepted.
If a manuscript is rejected an option to ‘Appeal Manuscript’ appears on the author's home page, from which the author can write to the Editor-in-Chief explaining the reasons for disagreeing with the editorial process. The Editor-in-Chief or an Editor may uphold the decision, or may request further information or consult again on the manuscript prior to making a decision regarding whether to reject or uphold the appeal.
Complaints should be addressed in writing to the Editor-in-Chief for consideration and any necessary action. Where a complaint remains unresolved, the complainant can refer the matter to the Committee on Publication Ethics (COPE).
If the author/s decide/s to revise the manuscript the changes made in the manuscript should be highlighted by using the track changes mode in MS Word or by using bold or colored text and respond to reviewers' comments with a separate word document. The revised manuscript must be uploaded on submission site menu typing as revised version.
To avoid withdrawal of a manuscript we sincerely request the authors especially the corresponding author and first author to address the following issues before submitting the manuscript for publication:
Manuscript may be withdrawn at any stage of review and publication process by submitting a request to the editorial office. Manuscript withdrawal will be permitted after submission only for the most compelling and inevitable causes.
If the author wants to withdraw a manuscript, the author needs to submit a completed form, signed by all authors of the manuscript withdrawal. The form is available from the editorial office of the journal. It should be wanted with a request e-mail.
Each author named in the manuscript have to meet at least one of the following ICMJE criteria ;
The corresponding author must confirm that all described authors fulfilled all authorship conditions described here. The corresponding author is the one individual who takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely way, and should be available after publication to respond to critiques of the work and cooperate with any requests from the journal for data or additional information should questions about the paper arise after publication. Although the corresponding author has primary responsibility for correspondence with the journal, editors will send copies of all correspondence to all listed authors.
All contributors who do not meet the criteria for authorship (Non-Author Contributors) should be listed in the “Acknowledgements” part.
The journal requires that all authors declare any potential sources of conflict of interest according to ICMJE recommendations.
Any interest or relationship, financial or otherwise that might influence an author's objectivity is considered as a potential source of conflict of interest. All authors must declare any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and any financial support including grants or other funding. These conditions must be disclosed when directly pertinent or associated with the study. The occurrence of any conflict of interest does not obviate the publication.
If the authors have no conflict of interest to declare, they must also state this in the manuscript clearly. It is the responsibility of the corresponding author to review this policy of the journal.
Benefits of Data Sharing
Gynecology, Obstetrics, and Reproductive Medicine (GORM) is an open-access journal that aims to create a transparent publishing policy. We think that sharing datasets is a crucial step for creating transparency. Shared datasets would contribute to the literature even more and sharing data is a great way for validation of the published studies. Furthermore, data sharing would enable other authors to contribute to the current study. Creating easily accessible datasets may also lead to opportunities for further studies. The following text summarizes the Data Sharing Policies of GORM.
GORM Encourages Data Sharing
We fully encourage our authors to deposit and share their relevant data except in cases with ethical issues regarding human rights or data privacy. There are several ways of data deposit and share. GORM fully supports all of the described modules which may be found online. We fully support the usage of relevant and well-known data repository sites. There are many well-known data repository sites and each one would be used for these purposes. For example:
Properties of Data
We encourage any files related to your result such as images (.jpg, .eps, tiff., etc.), codes, text files (.doc, .txt, etc.), scan files (.img, .dcm, etc.) or raw data. All data should be shared as they were initially generated to enable reuse and improve reproducibility.
Templates of “Data Availability Statement” for Author Use
Authors are also questioned about the data available regarding their study. On submission, authors should select at least one of the suitable “Data Availability Statements” text options below and noted in the Declaration Section of manuscript. The terms should also clarify when the dataset is available and who can reach these datasets.
|Availability of data
|Templates for Author Use
|Data are available in an open Access public repository.
|The data of this study are openly available in [repository name e.g “re3data”] at http://doi.org/[doi], reference number [reference number].
|Data are available upon request.
|The data of this study are available from the corresponding author upon reasonable request.
|Data are not publicly available but may be obtained from a third party.
|Data are available [from the authors / at URL] with the permission of [third party].
|Data available on request due to privacy/ethical restrictions
|The data are not publicly available due to privacy or ethical restrictions. The data of this study are available from the corresponding author upon reasonable request.
|There are no specific data regarding this study.
|Data are not available due to no new data were created or analyzed in this study.
|All of the data are included in the manuscript and uploaded as supplementary material.
|The data of this study are available in the supplementary material.
|Data is unavailable.
|Data are not available due to no new data were created or analyzed in this study.
|The author chooses to not share data
|Research data are not shared or not applicable
Manuscripts with a readily available dataset will add a data availability statement including the URL for reaching the repository storing the data. Authors with a preloaded dataset and a DOI number are asked to include the DOI number in their data availability statement.
When data are publicly available, authors should cite the data in the text and the reference list as below:
Authors; Year; Dataset title; Data repository; Version (if any); Persistent identifier (e.g. DOI)
Data access criteria
Authors or readers demanding a dataset that is available upon request may contact the corresponding author. In case of no return, the authors or readers demanding the dataset may contact the editorial board. All the authors are encouraged to share their datasets and may contact the editorial board for further questions.
The publication process at GORM aims improvement and dissemination of scientific information objectively and respectfully. Therefore, the policy in this process helps in improving the quality of the articles. Peer-reviewed articles support and materialize the scientific method and hence it is of utmost importance that all parties included in the publication process (authors, readers and researchers, publisher, reviewers and editors) comply with the standards of ethical considerations. GORM expects all parties to hold to the following ethical responsibilities.
The following ethical duties and responsibilities are concordant with the policies made by Committee on Publication Ethics (COPE).
The authors who submit their manuscripts to GORM are expected to comply with the following ethical responsibilities:
Author(s) must submit their own original studies to the journal. If they utilize or present the results of the other studies in the manuscript, they must make the in-text and end-text references accurately and completely.
People who have no intellectual contribution to the study should not be indicated as authors.
If there are conflicting interests or relations in the manuscripts submitted, these must be stated and explained.
Author(s) may be asked to supply their raw data during the review process of their manuscripts. In that circumstance, author(s) should be ready to submit their data and information to the corresponding editorial and scientific boards.
Authors should document that they have obtained ethics committee approval and informed consent in all research studies that involve patients, patient records, research participants, or databases.
For patient images that allow the identity of the patient to be identified, authors should document that they have obtained written permission from the patient(s) on whom the report is based.
Author(s) have the responsibility to inform the editor of the journal or publisher if they happen to notice a mistake or conflicting result in their study which is in early release or publication process and to cooperate with the editors during the correction or withdrawal process.
Authors cannot submit their studies to multiple journals simultaneously. Each submission can be made only after the previous one is completed. A study published in another journal cannot be submitted to GORM.
Author responsibilities given in a study (e.g.: adding an author, reordering of author names) after the review process has started.
Authors must follow the ethical standards for human experimentation established in the Declaration of Helsinki (World Medical Association Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277:925-6) or conform to the provisions of the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013; published in JAMA. 2013 Nov 27;310(20):2191-4). The editors should ensure that a manuscript originating from an institution has provided the approval of the requisite authority. This approval must be presented in the Materials and Methods section of the manuscript. For studies of human experimentation that require local institutional approval, authors must provide that they had obtained this approval before the experiment was started. If the authors declare that their study is exempt from Institutional Review Board approval, they should explain it in the Materials and Methods section of the manuscript. For reports originating from experiments on nonhuman animals or other species, authors must declare that the guidelines for the care and use of the animals approved by the local institution were followed.
Any reports of studies or trials involving human or animal subjects, or medical records, should contain a statement that the procedures of the study received ethics approval from the relevant regional or institutional ethics committee responsible for human experimentation or complied with regulations governing experimentation using animals.
All research studies, including those involving patients, patient records, research participants or databases, require ethics committee approval (or documented exemption from the Human Subjects Committee) and informed consent (or documented waiver of consent), both of which must be documented in the paper.
Studies involving animals must be conducted according to internationally accepted standards. For studies involving nonhuman primates or other species, authors must state the guidelines for the care and use of the animals approved by the local institution were followed under materials and methods section. The type(s) of nonhuman primates or other species used in an investigation must be named in the title, abstract, key words, and materials and methods sections of the manuscript. The necessary approvals must also be mentioned in materials and methods section. The authors are advised to comply with the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines, developed by the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs).
The editor and section editors should hold with the following ethical responsibilities that are based on the guides of "COPE Code of Conduct and Best Practice Guidelines for Journal Editors" published as open access by COPE.
General duties and responsibilities
Editors are responsible for each study published in GORM. In this respect, the editors have the following duties and responsibilities:
Relationships with Readers
Editors must make decisions taking into consideration of the knowledge, skills, and expectations of all readers, researchers, and practitioners need. They must also ensure that the published studies have an original contribution to the literature. Furthermore, they must take notice of the feedback received from researchers and practitioners and provide explanatory and informative feedback.
Relationships with Authors
Editors have the following roles and responsibilities in their relations with authors:
Editors must make positive or negative decisions about the studies' scientific importance, originality, validity, clarity in wording, and suitability with the journal's aims and scope.
Editors must accept the studies that are within the scope of the publication into the pre-review process unless there are serious problems with the structure of the study.
Editors must not ignore positive suggestions made by reviewers unless there are serious problems with the structure of the study.
New editors, unless they have serious concerns, should not change the previous editor's decisions about the studies.
Editors must take every effort to prevent possible deviations from the defined "Blind Review and Evaluation Processes".
Editors must present a comprehensive "Author's Guide" in answering queries by authors. This guide must be updated regularly.
Authors should be provided with explanatory and informative feedback.
Relationships with Reviewers
Editors have the following duties and responsibilities in their relations with reviewers:
Relationships with the Editorial Board
Editors should monitor that the members of the editorial board follow the procedures in accordance with the publication policies and guidelines, and should inform the members about the publication policies and developments. The editors should also train new members of the editorial board and provide the information they need.
Furthermore, editors should also:
Relationships with the Journal's Owner and Publisher
The relationship between the editors and the publisher is based on the principle of the independence of editors. All the decisions made by the editors are independent of the publisher and the owner of the journal as required by the agreement made between editors and publisher.
Editorial and Blind Review Processes
Editors are obliged to comply with the policies of the "Blind Review and Evaluation Process" stated in the journal's publication policies. Therefore, the editors should ensure that each manuscript is reviewed in an unbiased, fair, and timely manner.
Editors should ensure that articles in the journal are published in accordance with the publication policies of the journal and international standards.
Protection of Personal Information
Editors are supposed to protect the personal information related to the subjects or visuals in the studies being reviewed and to reject the study if there is no documentation of the subjects' consent. Furthermore, editors are supposed to protect the personal information of the authors, reviewers, and readers.
Encouraging Ethical Rules and Protection of Human and Animal Rights
Editors are supposed to protect human and animal rights in the studies being reviewed and should reject the experimental studies that do not have ethical and related committee’s approval.
Precautions against possible Abuse and Malpractice
Editors are supposed to take precautions against possible abuse and malpractice. They should conduct investigations meticulously and objectively in determining and evaluating complaints about such situations. They should also share the results of the investigation.
Ensuring Academic Integrity
Editors should ensure that the mistakes, inconsistencies, or misdirections in studies are corrected quickly.
Protection of Intellectual Property Rights
Editors are responsible for protecting the intellectual property rights of all the articles published in the journal and the rights of the journal and author(s) in cases where these rights are violated. Also, editors should take the necessary precautions in order to prevent the content of all published articles from violating the intellectual property rights of other publications. See Plagiarism Check
Constructiveness and Openness to Discussion
Editors must examine the complaints from authors, reviewers, or readers and respond to them in an explanatory and enlightening manner.
Political and Economic Apprehensions
The independent decision of the editors is not influenced by the owner of the journal, publisher, or any other political or economical factor
Editors, acknowledging that there may be conflicting interests between reviewers and other editors, guarantee that the publication process of the manuscripts will be completed in an independent and unbiased manner.
The fact that all manuscripts are reviewed through "Blind Review" has a direct influence on the publication quality. This process ensures confidentiality by an objective and independent review. The review process at GORM is carried out on the principle of double-blind review. Reviewers do not contact the authors directly, and their reviews and comments are processed through the journal management system. In this process, the reviewer's views on the evaluation forms and full texts are assigned to the author(s) by the editor. Therefore, the reviewers doing a review for GORM are supposed to bear the following ethical responsibilities:
The publisher of GORM is conscious of the fact that they should follow the ethical responsibilities below and act accordingly:
Editors are responsible for all the processes of the manuscripts submitted to GORM. Within this framework, ignoring the economic or political interests, the decision-makers are the editors.
The publisher undertakes the independent editorial decision.
The publisher protects the intellectual property rights of all the articles published in GORM and holds the responsibility to keep a record of each unpublished article.
Should you encounter any unethical act or content in GORM apart from the ethical responsibilities listed above, please notify the journal by e-mail at [email protected]
After acceptance, the manuscripts are subjected to the processes of plagiarism detection, preparation of bibliography, cross-reference and reference check, layout and galley, assigning a DOI number, and being put into an early release. The manuscripts in the early release are published in the volume and issue determined by the editorial board.
Scientific misconduct includes but is not necessarily limited to data fabrication; data falsification including deceptive manipulation of images; duplicate publication and plagiarism (http://www.icmje.org/recommendations/ browse/publishing-and-editorial-issues/ scientific-misconduct-expressions-of-concern-and-retraction.html) (https://publicationethics.org/misconduct). When scientific misconduct is alleged, or concerns are otherwise raised about the conduct or integrity of work described in submitted or published papers, the editor should initiate appropriate procedures detailed by such committees such as the Committee on Publication Ethics (COPE) and may choose to publish an expression of concern pending the outcomes of those procedures.
In accordance with its publishing policies, GORM obliges each manuscript to be detected for plagiarism. Therefore, the manuscripts are scanned and compared for plagiarism either by Turnitin or iThenticate software, chosen by the editorial staff. The matches found in each study after plagiarism detection are analyzed in detail and those matches with correct reference and cross-reference are sorted. In the next step, the mistakes in the remaining matches are determined and reported to the editorial board. IThenticate also checks for self-plagiarism or redundancy therefore authors should be cautious about citing the text from their previously published works. The board, then, makes a final decision in light of the plagiarism detection report. The author(s) may be asked to correct the mistakes listed in the report or the study may be returned to the author(s)/rejected. (Suspected plagiarism in a submitted manuscript) (https://publicationethics.org/sites/default/files/plagiarism-submitted-manuscript-cope-flowchart.pdf)
If a case of plagiarism comes to light after a paper is published, the journal will conduct a preliminary investigation. If plagiarism is found, the journal will contact the author's institute and funding agencies. The paper containing the plagiarism will also be obviously marked on each page of the PDF. Depending on the extent of the plagiarism, the paper may also be formally retracted. (Suspected plagiarism in a published article) (https://publicationethics.org/sites/default/files/plagiarism-published-article-cope-flowchart.pdf)
Scientific research builds upon previous studies. In new studies, references and attributions to the previous studies are provided within the framework of certain rules. Intentional or unintentional mistakes in scientific studies harm the reliability of the study and publication. In accordance with its publication ethics, GORM deems it as an obligation for the accepted manuscripts to give references and attributions in correct and complete form. Therefore, after acceptance, a company chosen by the editorial board checks each study in terms of bibliography, referencing, and attribution.
The full texts of the accepted manuscripts are processed for bibliography, referencing, and attribution checks in the following steps:
The bibliography is prepared according to the format of the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (“National Library of Medicine (NLM)” style, as outlined in the ICMJE sample references).
The in-text references of the references given in the bibliography should be in line with rules and regulations, and mistakes are corrected.
Attributions of the in-text references are checked. The author(s) is asked to provide the missing ones, and the incorrect ones are corrected.
For the manuscripts, the English rules and regulations of referencing are used.
GORM requires that the articles be printed in a common type of and complete page layout for formal integrity, readability, and standards. Therefore, the manuscripts whose plagiarism detection and bibliography preparation are finished are sent to a company chosen by the editorial board for layout and galley.
The Editors reserve the right to edit a manuscript for grammar, house style, scientific and statistical clarity, and overall length while maintaining the scientific accuracy of the report. Authors may be asked to incorporate editorial amendments of spelling, grammar, house style and to check minor inconsistencies in the text or reference list, together with scientific and/or statistical corrections, before returning a revised manuscript for final approval by the Editor. Failure to make scientific, statistical, or editorial amendments could result in delayed acceptance and publication.
Once the manuscript has been typeset; one set of page proofs (as PDF files) will be sent by e-mail to the corresponding author. Therefore a working email address must be provided for the corresponding author. Acrobat Reader version 9 or higher will be required to read this file. This software can be downloaded (free of charge) from the following website: https://get.adobe.com/tr/reader/. The latest version of the software will let the corresponding author open, read on screen and edit the proof electronically. The corresponding author may prefer to print the pdf, add the corrections offline, scan the corrected proof, and attach it to the reply mail.
Further instructions will be sent with the proof. To avoid publication delays proofs should be checked immediately and returned by email indicated on the proofs within 48 hours. Corrections by other means will not be accepted. It is important to ensure that all corrections are sent back to the journal in one communication: checking carefully before replying is very important, as the inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely the responsibility of the corresponding author. The publisher may proceed with the publication of the article if no response is received within 48 hours.
Authors are advised that they are responsible for proofreading the text, references, tables, and figures for absolute accuracy. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. New material cannot be accepted at this stage and substantial rewriting of paragraphs is not permitted. Should authors insist on doing so, then the costs will be charged to the author and the journal will not be responsible for typesetting errors arising from these changes.
The PDF file of the article can be downloaded from the website as soon as an early view is available. This is an open-access journal that all content is freely available without any charge. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication.
Digital Object Identifier (DOI) is a unique access number that enables the identification and accessibility of each article published electronically. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The DOIs are guaranteed never to change. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information.
Each article published in GORM or the early release will be assigned a DOI number. After acceptance, the manuscripts which are checked for plagiarism and bibliography and ready for publication are given a DOI number by the Editorial Board.
GORM values the dissemination of up-to-date and original information. Those manuscripts that are accepted after the review process, revised and edited for publication, and the authors' final corrections have been incorporated and therefore whose process for publication is over does not need to wait for the next scheduled print issue and are published electronically as "Articles in Press". On average it takes a few days from being sent to production (usually straight after acceptance) to a paper appearing online. The manuscripts in the articles in the press may not be the final version to be seen in the normal issue. Minor editing may be done on the final version to be published. They are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked. After publication, the DOI remains valid and can continue to be used to cite and access the article. Later, these manuscripts are given page numbers and published in the volume and issue found suitable by the editorial board.
Authors may now enter their ORCID identifier during registration. Please go to the “Update My Information” page to enter an existing identifier or to register with ORCID (http://orcid.org/). The author(s) must identify potential conflicts of interest of financial or other nature on submission. Authors should fill out the author agreement form accurately and provide as much information as possible, regardless of the amount. Identify all sources of financial support of the study, including the provision of supplies or services or financial compensation (e.g., salary) from a commercial organization on the title page. All sponsor names must be provided. Include an explanation of any role the sponsor(s) had in the study design; collection, analysis, and interpretation of data; writing of the report; the decision to submit the report for publication; or a statement that the sponsor(s) had no such involvement. Disclose any financial involvement that could represent potential conflicts of interest by checking the appropriate box on the author agreement form and listing the potential conflicts in an attachment to the author agreement form.
INDEXING AND ABSTRACTING IN